发布了文章
关于甲状腺癌术后碘治疗的个人观点
近几年碘治疗大有流行之风,很多单位手术后让患者常规行碘治疗。低危患者(分化型甲状腺癌低风险组的占85%~90%,包括乳头状癌和滤泡状癌)不能从碘治疗中受益碘治疗指征:明显的腺外侵犯、血管侵犯、多发淋巴结转移、全切除术后持续高甲状腺球蛋白,远处转移北京大学肿瘤医院头颈外科于文斌碘治疗在降低复发率和提高生存率方面的潜在好处仍存在争议,无大规模随机临床试验(以下为主要文献) 21. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for welldifferentiated thyroid cancer. J Clin Endocrinol Metab. 2004 Aug;89 (8):3668-76. 22. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and longterm outcome in 2444 consecutively treated patients. World J Surg. 2002 Aug;26(8):879-85. 23. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63. 当前浏览器不支持播放视频,建议使用火狐或者谷歌浏览器